Since its introduction by Mihata et al. in 2013, SCR has undergone various developments, particularly in selecting graft materials, which have seen significant variation. This is likely one of the reasons for the inconsistent clinical outcomes observed in previous literature regarding SCR20. Previous studies by Mihata have demonstrated that using a fascia lata autograft provides significant biomechanical benefits in preventing superior migration of the humeral head and reducing subacromial contact pressure10,16. Moreover, it has been shown that, in comparison to fascia lata autografts, using a single-layer dermal graft is less effective due to its inadequate thickness16. In other words, graft thickness is critically important, which is one of the key advantages of using the tensor fascia lata. Apart from thickness, the fascia lata is also shown to possess superior stiffness. In experiments by Mihata et al., it was found that dermal allografts used in SCR can elongate by up to 15% after only a few physiological shoulder movements, whereas fascia lata grafts do not exhibit this elongation21. This may also explain the frequent dermal graft failures reported in previous clinical outcomes12. Thus, we have described the surgical technique and approach using fascia lata graft to achieve favorable clinical outcomes in SCR. The most critical step in this procedure is obtaining a graft of sufficient thickness, and particular attention must be given to ensuring the graft has adequate length and width during the initial harvest of the fascia lata.
As previously mentioned, there have been numerous variations in SCR techniques in recent years11,13,18,22,23. In addition to the dermis graft, which has shown variable prognosis, the autologous LHBT is another widely accepted graft option. The use of the LHBT, also known as the Chinese way, has undergone various modifications since its introduction in 201711,22. These variations include different routing techniques, as well as combinations with fascia lata and dermis grafts13. The biceps tendon graft has also demonstrated promising outcomes; however, clinical data directly comparing it with the fascia lata graft remains limited, highlighting the need for further research.
Although using fascia lata for SCR is a well-established procedure and has demonstrated excellent mid- to long-term outcomes in reports by Mihata et al.9,19, it still presents certain limitations. First, the harvest of fascia lata can lead to donor site morbidity, including pain and complications at the harvest site. A study by Ângelo et al. evaluated this morbidity in 15 patients over a mean follow-up of 2.5 years. They reported that 20% of patients experienced mild donor-site pain, and 13.3% had mild thigh hypoesthesia. Importantly, no patients reported functional deficits or dissatisfaction related to the donor site24. Additionally, fascia lata autografts may vary in thickness and quality, potentially affecting graft performance. The quality of the graft may determine whether the outcomes of SCR surgery are reproducible. Furthermore, fascia lata requires more extensive preparation and surgical time compared to alternative grafts, such as dermal allografts. These factors contribute to its challenges in clinical practice. Thus, following an established protocol when using fascia lata to achieve favorable outcomes is essential, which is a key objective conveyed in this article.
Compared with traditional methods for treating massive irreparable rotator cuff tears, SCR stands out as a joint-preserving technique, providing patients with effective pain relief and restoration of range of motion. This method aims to restore glenohumeral stability by reconstructing the superior capsule, which in turn prevents superior migration of the humeral head, thereby further delaying the progression of cuff arthropathy. In the future, there may be more studies combining different surgical techniques, and comparing these various approaches will be an important direction for further research.